Who cares if anyone visited? That would only be of benefit to someone who actually doubted the reality of the business. And, what possible benefit would it be for investors to visit the lab when the CEO stands in front of you and lies about the dilution being over - and then you ignore that lie as if it doesn't exist.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.